CurrentCapital BluecrossPolicy MP 2.097

Paraspinal Surface Electromyography to Evaluate and Monitor Back Pain

This policy governs the use and coverage stance for paraspinal surface electromyography (SEMG) to evaluate and monitor back pain for Capital BlueCross members and applicable products.

Policy Summary

PayerCapital Bluecross

PolicyParaspinal Surface Electromyography to Evaluate and Monitor Back Pain

Policy CodePolicy MP 2.097

Change TypeNo material change

Effective DateJan 1, 2026

Next Review DateJul 10, 2025

Key ActionExpect that claims for paraspinal SEMG will be treated as investigational and may be denied; verify member benefits and medical necessity before billing.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Not Coveredcoverage stance

FDA-cleared devicesFDA status

No standard criteriaevidence gap

Physiatrists/Chiroscommon users

MP 2.097policy

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria

General coverage stance

Covered when ALL of the following are met

Investigational determination: Paraspinal SEMG is considered investigational for diagnosis or monitoring of back pain due to insufficient evidence that it improves health outcomes or informs management.

No standard criteria for normal/abnormal SEMG measurements have been established and studies do not report health outcomes or demonstrate impact on patient management.

Paraspinal surface electromyography (SEMG) is considered investigational and is excluded from coverage for the evaluation or monitoring of back pain. Capital BlueCross does not cover claims for paraspinal SEMG because there is insufficient evidence that the procedure improves health outcomes or informs management decisions.

Coding

Investigational / Not covered procedure codesmixedNot Covered

S3900	Investigational; paraspinal surface electromyography (SEMG) (listed in policy as investigational)
95999	Procedure code listed in investigational coding section
96002	Procedure code listed in investigational coding section
96004	Procedure code listed in investigational coding section
97799	Procedure code listed in investigational coding section

Coding table (updated note)mixed

No codes listed

Provider Actions & Billing Impact

Denial Risk

Investigational — Not Covered

Paraspinal surface electromyography (SEMG) is considered investigational and not covered. Claims for SEMG may be subject to denial; listed billing codes are identified as investigational and not eligible for routine reimbursement.

Policy Number: MP 2.097
Policy Title: PARASPINAL SURFACE ELECTROMYOGRAPHY TO EVALUATE AND MONITOR BACK PAIN

Note

Coverage Contingent on Member Benefits

This policy applies to Capital Blue Cross and affiliated companies; final claim payment is subject to the member's benefit program, eligibility on the date of service, and medical necessity determinations.

Coverage contingent on member benefits, eligibility, and medical necessity
Policy applies to Capital Blue Cross and affiliates

Background

Back pain has multiple potential causes including disc, facet, nerve-root, and muscular pathology. Most cases of acute low back pain improve with conservative management (for example, activity modification and physical therapy), and advanced diagnostic testing is generally reserved for patients with red flags or symptoms that persist beyond 4–6 weeks.

Definitions

Paraspinal SEMG — definition and brief description of the procedure

DefinitionParaspinal surface electromyography (SEMG) is a noninvasive procedure using single or arrays of surface electrodes placed on the skin over paraspinal muscles to record summed electrical activity at rest, in various positions, or after exercises.

Procedure techniqueElectrodes (single or fixed arrays) are applied to the skin over paraspinal muscles; recordings can be made with handheld devices or multi-sensor systems and analyzed for amplitude, root mean square, or spectral measures (e.g., median frequency).

Intended useInvestigated to evaluate paraspinal muscle function, identify abnormal activation patterns (spasm, tenderness, limited range of motion, postural disorders), monitor response to therapy, and assess functional capacity (e.g., lifting, return-to-work).

Contrast to needle EMGSEMG records summation from muscle groups via surface electrodes and is noninvasive, differing from needle electromyography which records individual muscle electrical activity invasively.

Surface EMG (SEMG) — referenced usage in studies and as an electrophysiologic measure

Conservative Treatment Requirements

Conservative therapy requirement

Conservative treatment before advanced diagnostics

Usual initial management: Most cases of acute low back pain resolve with conservative therapy (e.g., physical therapy and activity modification); initial imaging or other diagnostic testing is generally not recommended unless red flag signs are present or pain persists for more than 4 to 6 weeks.4-6 weeks

Red flag findings include significant trauma, history of cancer, unrelenting night pain, fevers or chills, and progressive motor or sensory deficits.

Frequency Limits

Frequency limits

Frequency limits stated in policyNo frequency limits specified in the provided text for paraspinal SEMG.

Policy history relevanceMultiple consensus reviews (2020–2024) cited; none added frequency or utilization limits in the excerpts provided.

Implication for billingBecause no frequency limits are specified, claims review should follow member benefits and medical necessity determinations as usual.

Imaging Requirements

Note

Diagnostic imaging is conditional — reserved for red flags or persistent symptoms

Imaging (for example MRI) is used to identify anatomic pathology in back pain, but imaging is generally reserved for red flags or symptoms persisting beyond the initial conservative management period.

Imaging should be correlated with the clinical picture and is not routinely recommended in the initial management of acute low back pain.

Note

No imaging requirements specified in excerpts

The provided excerpts do not specify any required imaging studies as a precondition for SEMG or list imaging requirements tied to authorization or coverage.

Not Covered

Paraspinal SEMG to diagnose or monitor back pain is not covered by this policy because it is considered investigational. Providers should expect that claims for this indication may be denied.

No additional explicit procedures or indications beyond the investigational exclusion for paraspinal SEMG are listed in the provided policy excerpts; see the policy history for reviews and coding updates.

Policy Summary

PayerCapital Bluecross

PolicyParaspinal Surface Electromyography to Evaluate and Monitor Back Pain

Policy CodePolicy MP 2.097

Change TypeNo material change

Effective DateJan 1, 2026

Next Review DateJul 10, 2025

Key ActionExpect that claims for paraspinal SEMG will be treated as investigational and may be denied; verify member benefits and medical necessity before billing.

SourceLink

On This Page

Note

Conservative Care Context

Conservative therapy (e.g., physical therapy) and continuation of normal activities within pain limits is the usual initial approach for acute low back pain; initial diagnostic testing (including SEMG) is generally not recommended unless red flag signs are present or pain persists >4–6 weeks.

SEMG is not part of initial conservative management for acute low back pain
Red flag findings (e.g., significant trauma, history of cancer, unrelenting night pain, fevers/chills, progressive motor or sensory deficits) warrant further evaluation

Step Therapy

Administrative / Step Therapy and Prior Authorization

No prior authorization or step therapy requirements are specified in this policy excerpt. Providers should verify any product-specific administrative requirements through benefit verification prior to service.

No step therapy requirements specified in policy excerpts
No prior authorization requirements specified in policy excerpts — verify member-specific requirements

Documentation Required

Policy History / Administrative Notes

Policy history entries note consensus reviews and that coding, background, rationale, and references were reviewed on multiple dates.

Policy history documents multiple consensus reviews and coding review activities
Most recent noted update: 07/10/2025 — coding table and references updated

Research usageSEMG has been used in multiple studies to classify low back pain phenotypes and paraspinal muscle impairments (e.g., spectral parameter classification, lifting-capacity evaluation, neural network analyses).

Examples of study typesPublished reports include classification of low back pain using spectral SEMG parameters, neural-network analyses of lifting capacity, and investigations of neuromuscular patterns during trunk motions.

Clinical presentations studiedApplied in research for chronic low back pain, fatigue assessment during isometric endurance tasks, and to discriminate sufferers from normal subjects.

Device contextSEMG is implemented both as standalone single-electrode or fixed-array devices and as part of multi-sensor FDA-cleared systems used in clinical studies and practice evaluations.